366 related articles for article (PubMed ID: 32710500)
1. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
Kim JS; Lee KH; Kim GE; Kim S; Yang JW; Li H; Hong SH; Ghayda RA; Kronbichler A; Koyanagi A; Jacob L; Shin JI; Smith L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11926-11933. PubMed ID: 33275265
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Glenthøj A; Jakobsen LH; Sengeløv H; Ahmad SA; Qvist K; Rewes A; Poulsen CB; Overgaard UM; Mølle I; Severinsen MT; Strandholdt CN; Maibom J; Kodahl AR; Ryg J; Ravn P; Johansen IS; Helsø SN; Jensen-Fangel S; Kisielewicz J; Wiese L; Helleberg M; Kirk O; Clausen MR; Frederiksen H
Eur J Haematol; 2021 Jan; 106(1):72-81. PubMed ID: 32939853
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection in patients with haematological malignancies: A single-centre survey in the latest Omicron wave in China.
Zhu X; Jiang Q; Lu J; Sun Y; Zhao X; Yang S; Tang F; Yu W; Zhao T; Liu X; Jia J; Duan W; Hu L; Wang J; Liu Y; Peng N; Dou X; Ma R; Fu Q; Wang H; Liu K; Huang X; Jiang H
Br J Haematol; 2023 Jul; 202(1):31-39. PubMed ID: 37092433
[TBL] [Abstract][Full Text] [Related]
7. Multivariate mortality analyses in COVID-19: Comparing patients with cancer and patients without cancer in Louisiana.
Lunski MJ; Burton J; Tawagi K; Maslov D; Simenson V; Barr D; Yuan H; Johnson D; Matrana M; Cole J; Larned Z; Moore B
Cancer; 2021 Jan; 127(2):266-274. PubMed ID: 33112411
[TBL] [Abstract][Full Text] [Related]
8. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
Booth S; Curley HM; Varnai C; Arnold R; Lee LYW; Campton NA; Cook G; Purshouse K; Aries J; Innes A; Cook LB; Tomkins O; Oram HS; Tilby M; Kulasekararaj A; Wrench D; Dolly S; Newsom-Davies T; Pettengell R; Gault A; Moody S; Mittal S; Altohami M; Tillet T; Illingworth J; Mukherjee L; Apperly J; Ashcroft J; Rabin N; Carmichael J; Cazier JB; Kerr R; Middleton G; Collins GP; Palles C;
Br J Haematol; 2022 Feb; 196(4):892-901. PubMed ID: 34761389
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
[TBL] [Abstract][Full Text] [Related]
10. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
Booth S; Willan J; Wong H; Khan D; Farnell R; Hunter A; Eyre T; Katz H; Dungarwalla M; Chen L; Browning J; Polzella P; Gray N; Neelakantan P; Dhillon EK; Dutton D; Sternberg A; Prideaux S; Collins GP; Peniket A
Eur J Haematol; 2020 Oct; 105(4):476-483. PubMed ID: 32544294
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro S; Ljungman P; Mikulska M; Hirsch HH; von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Masculano RC; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; ; Pagano L
Leukemia; 2022 Jun; 36(6):1467-1480. PubMed ID: 35488021
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.
Fox TA; Troy-Barnes E; Kirkwood AA; Chan WY; Day JW; Chavda SJ; Kumar EA; David K; Tomkins O; Sanchez E; Scully M; Khwaja A; Lambert J; Singer M; Roddie C; Morris EC; Yong KL; Thomson KJ; Ardeshna KM
Br J Haematol; 2020 Oct; 191(2):194-206. PubMed ID: 32678948
[TBL] [Abstract][Full Text] [Related]
15. IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery.
Clement ND; Hall AJ; Makaram NS; Robinson PG; Patton RFL; Moran M; Macpherson GJ; Duckworth AD; Jenkins PJ
Bone Joint J; 2020 Dec; 102-B(12):1774-1781. PubMed ID: 33249904
[TBL] [Abstract][Full Text] [Related]
16. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
Wood WA; Neuberg DS; Thompson JC; Tallman MS; Sekeres MA; Sehn LH; Anderson KC; Goldberg AD; Pennell NA; Niemeyer CM; Tucker E; Hewitt K; Plovnick RM; Hicks LK
Blood Adv; 2020 Dec; 4(23):5966-5975. PubMed ID: 33278301
[TBL] [Abstract][Full Text] [Related]
20. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Russell B; Moss CL; Shah V; Ko TK; Palmer K; Sylva R; George G; Monroy-Iglesias MJ; Patten P; Ceesay MM; Benjamin R; Potter V; Pagliuca A; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Sita-Lumsden A; Josephs D; Enting D; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Harrison C; Fields P; Wrench D; Rigg A; Sullivan R; Kulasekararaj A; ; Dolly S; Van Hemelrijck M
Br J Cancer; 2021 Sep; 125(7):939-947. PubMed ID: 34400804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
